chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness, Vaccination site pain
Clinical narrative: Arm is tender now; Pain in her arm was uncomfortable, bothered me for 10 days; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Arm is tender now) and VACCINATION SITE PAIN (Pain in her arm was uncomfortable, bothered me for 10 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.   No Medical History information was reported.  On 18-Feb-2021 at 2:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TENDERNESS (Arm is tender now). an unknown date, the patient experienced VACCINATION SITE PAIN (Pain in her arm was uncomfortable, bothered me for 10 days). The patient was treated with MENTHOL, METHYL SALICYLATE (SALONPAS [MENTHOL;METHYL SALICYLATE]) at an unspecified dose and frequency. At the time of the report, TENDERNESS (Arm is tender now) and VACCINATION SITE PAIN (Pain in her arm was uncomfortable, bothered me for 10 days) outcome was unknown.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  The patient reported that she received the first dose of the Moderna COVID-19 vaccine on 18-Feb-2021 at 2:30PM, in her upper left arm. 11 hours later, her arm was quite sore. She described the pain in her arm to be very uncomfortable and bothered her for 10 days. She used a Salonpas patch tp help alleviate the discomfort. At this time, her arm is still tender. She does not take any other medications. She wanted to know whether Moderna advises on a specific needle size to use for the injection of the vaccine.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Achy to shoulder in arm of injection; Soreness at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Achy to shoulder in arm of injection) and VACCINATION SITE PAIN (Soreness at site of injection) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included LISINOPRIL and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Achy to shoulder in arm of injection) and VACCINATION SITE PAIN (Soreness at site of injection). At the time of the report, PAIN IN EXTREMITY (Achy to shoulder in arm of injection) and VACCINATION SITE PAIN (Soreness at site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever of 101.8; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101.8) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of 101.8). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PYREXIA (Fever of 101.8) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: ill; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (ill) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (ill). At the time of the report, ILLNESS (ill) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: injection site red patch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site red patch) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site red patch). At the time of the report, VACCINATION SITE ERYTHEMA (injection site red patch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Rash macular, Rash morbilliform
Clinical narrative: Rash - dark red blotches about the size of a dime; Whole leg is covered with this and it is very unsightly/Rash looks like measles; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Rash - dark red blotches about the size of a dime) and RASH MORBILLIFORM (Whole leg is covered with this and it is very unsightly/Rash looks like measles) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced RASH MACULAR (Rash - dark red blotches about the size of a dime) and RASH MORBILLIFORM (Whole leg is covered with this and it is very unsightly/Rash looks like measles). The patient was treated with CLOBETASOL PROPIONATE for Rash, at a dose of 0.5 %. At the time of the report, RASH MACULAR (Rash - dark red blotches about the size of a dime) and RASH MORBILLIFORM (Whole leg is covered with this and it is very unsightly/Rash looks like measles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow-up received on 14-Jun-2021 and does not contain any new information
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Decreased appetite, Dizziness, Nausea
Clinical narrative: Injection site arm was hot to the touch; Injection site arm was hard; Injection site arm became red; Injection site arm was swollen; Nausea; Chills; No appetite; Dizziness; Fever of 103°F; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site arm was hot to the touch), DECREASED APPETITE (No appetite), DIZZINESS (Dizziness), VACCINATION SITE INDURATION (Injection site arm was hard) and PYREXIA (Fever of 103°F) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Autoimmune disorder. Concomitant products included PREDNISONE for Autoimmune disorder NOS.   On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced PYREXIA (Fever of 103°F). On 01-Mar-2021, the patient experienced DECREASED APPETITE (No appetite), DIZZINESS (Dizziness), NAUSEA (Nausea) and CHILLS (Chills). On 03-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site arm was hot to the touch), VACCINATION SITE INDURATION (Injection site arm was hard), VACCINATION SITE ERYTHEMA (Injection site arm became red) and VACCINATION SITE SWELLING (Injection site arm was swollen). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and IBUPROFEN for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Injection site arm was hot to the touch), DECREASED APPETITE (No appetite), DIZZINESS (Dizziness), VACCINATION SITE INDURATION (Injection site arm was hard), PYREXIA (Fever of 103°F), NAUSEA (Nausea), CHILLS (Chills), VACCINATION SITE ERYTHEMA (Injection site arm became red) and VACCINATION SITE SWELLING (Injection site arm was swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Body temperature: 103 (High) 103 degree fahrenheit. On 02-Mar-2021, Body temperature: 100 (High) 100 degree fahrenheit. On 03-Mar-2021, Body temperature: 102 (High) 102 degree fahrenheit. On 04-Mar-2021, Body temperature: 99.5 (Inconclusive) 99.5 degree fahrenheit.         patient also used cold compresses as treatment. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site induration, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site arm was hot to the touch; Injection site arm was hard; Injection site arm became red; Injection site arm was swollen; Nausea; Chills; No appetite; Dizziness; Fever of 103°F; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site arm was hot to the touch), DECREASED APPETITE (No appetite), DIZZINESS (Dizziness), VACCINATION SITE INDURATION (Injection site arm was hard) and PYREXIA (Fever of 103°F) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Autoimmune disorder. Concomitant products included PREDNISONE for Autoimmune disorder NOS.   On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced PYREXIA (Fever of 103°F). On 01-Mar-2021, the patient experienced DECREASED APPETITE (No appetite), DIZZINESS (Dizziness), NAUSEA (Nausea) and CHILLS (Chills). On 03-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site arm was hot to the touch), VACCINATION SITE INDURATION (Injection site arm was hard), VACCINATION SITE ERYTHEMA (Injection site arm became red) and VACCINATION SITE SWELLING (Injection site arm was swollen). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and IBUPROFEN for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Injection site arm was hot to the touch), DECREASED APPETITE (No appetite), DIZZINESS (Dizziness), VACCINATION SITE INDURATION (Injection site arm was hard), PYREXIA (Fever of 103°F), NAUSEA (Nausea), CHILLS (Chills), VACCINATION SITE ERYTHEMA (Injection site arm became red) and VACCINATION SITE SWELLING (Injection site arm was swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Body temperature: 103 (High) 103 degree fahrenheit. On 02-Mar-2021, Body temperature: 100 (High) 100 degree fahrenheit. On 03-Mar-2021, Body temperature: 102 (High) 102 degree fahrenheit. On 04-Mar-2021, Body temperature: 99.5 (Inconclusive) 99.5 degree fahrenheit.         patient also used cold compresses as treatment. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain on the foot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on the foot) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain on the foot). At the time of the report, PAIN IN EXTREMITY (Pain on the foot) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant and treatment information were not reported.    This case was linked to MOD-2021-035550 (Patient Link).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Bowel movement irregularity
Clinical narrative: stomach ache; multiple bowel movements; GI tract discomfort; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache), BOWEL MOVEMENT IRREGULARITY (multiple bowel movements) and ABDOMINAL DISCOMFORT (GI tract discomfort) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included Irritable bowel syndrome.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), BOWEL MOVEMENT IRREGULARITY (multiple bowel movements) and ABDOMINAL DISCOMFORT (GI tract discomfort). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and TRAMADOL at a dose of 1 dosage form. At the time of the report, ABDOMINAL PAIN UPPER (stomach ache), BOWEL MOVEMENT IRREGULARITY (multiple bowel movements) and ABDOMINAL DISCOMFORT (GI tract discomfort) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: irregular heart beat; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (irregular heart beat) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included Cardiac disorder NOS (The patient has had some heart issues in the past, but nothing serious.). Concurrent medical conditions included Caffeine (sensitivity to caffeine).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PALPITATIONS (irregular heart beat). On 05-Feb-2021, PALPITATIONS (irregular heart beat) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Drug hypersensitivity, Swelling face
Clinical narrative: Swollen Face; Potential Allergic Reaction to the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swollen Face) and DRUG HYPERSENSITIVITY (Potential Allergic Reaction to the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced SWELLING FACE (Swollen Face) and DRUG HYPERSENSITIVITY (Potential Allergic Reaction to the vaccine). At the time of the report, SWELLING FACE (Swollen Face) and DRUG HYPERSENSITIVITY (Potential Allergic Reaction to the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No medical history was provided by the reporter. No relevant concomitant medications reported.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Fatigue, Nasal congestion
Clinical narrative: Chest Pain; Nasal Congestion; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest Pain), NASAL CONGESTION (Nasal Congestion) and FATIGUE (Tiredness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest Pain), NASAL CONGESTION (Nasal Congestion) and FATIGUE (Tiredness). At the time of the report, CHEST PAIN (Chest Pain), NASAL CONGESTION (Nasal Congestion) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Lymphadenopathy, Neck pain, Pain, Pain in extremity
Clinical narrative: Pains from the top of her shoulders to her fingers; Neck hurts; Upper arm hurts; Shoulder hurts; Lymph node hurts; Soreness of arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pains from the top of her shoulders to her fingers), NECK PAIN (Neck hurts), PAIN IN EXTREMITY (Upper arm hurts), VACCINATION SITE PAIN (Soreness of arm) and ARTHRALGIA (Shoulder hurts) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012N20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type II diabetes mellitus, Hypertension, Osteoporosis, Arthritis, Fibromyalgia and Neuropathy.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness of arm). On 14-Feb-2021, the patient experienced NECK PAIN (Neck hurts), PAIN IN EXTREMITY (Upper arm hurts), ARTHRALGIA (Shoulder hurts) and LYMPHADENOPATHY (Lymph node hurts). On 28-Feb-2021, the patient experienced PAIN (Pains from the top of her shoulders to her fingers). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Pain management, at a dose of 1 dosage form. At the time of the report, PAIN (Pains from the top of her shoulders to her fingers) and VACCINATION SITE PAIN (Soreness of arm) outcome was unknown and NECK PAIN (Neck hurts), PAIN IN EXTREMITY (Upper arm hurts), ARTHRALGIA (Shoulder hurts) and LYMPHADENOPATHY (Lymph node hurts) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pains from the top of her shoulders to her fingers; Neck hurts; Upper arm hurts; Shoulder hurts; Lymph node hurts; Soreness of arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pains from the top of her shoulders to her fingers), NECK PAIN (Neck hurts), PAIN IN EXTREMITY (Upper arm hurts), VACCINATION SITE PAIN (Soreness of arm) and ARTHRALGIA (Shoulder hurts) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012N20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type II diabetes mellitus, Hypertension, Osteoporosis, Arthritis, Fibromyalgia and Neuropathy.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness of arm). On 14-Feb-2021, the patient experienced NECK PAIN (Neck hurts), PAIN IN EXTREMITY (Upper arm hurts), ARTHRALGIA (Shoulder hurts) and LYMPHADENOPATHY (Lymph node hurts). On 28-Feb-2021, the patient experienced PAIN (Pains from the top of her shoulders to her fingers). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Pain management, at a dose of 1 dosage form. At the time of the report, PAIN (Pains from the top of her shoulders to her fingers) and VACCINATION SITE PAIN (Soreness of arm) outcome was unknown and NECK PAIN (Neck hurts), PAIN IN EXTREMITY (Upper arm hurts), ARTHRALGIA (Shoulder hurts) and LYMPHADENOPATHY (Lymph node hurts) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased, Headache, Vaccination site pain
Clinical narrative: Sore arm; Blood sugar was 285; Bad headaches all night long; A spontaneous report was received from a Consumer concerning a 70-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and developed sore arm, bad headaches all night long and her blood sugar was 285.  The patient's medical history included receving first dose of COVID-19 vaccine on 02 Feb 2021. No concomitant product use was reported.  On 02 Feb 2021, the patient received her first of two planned doses of mRNA-1273 (batch number: 012MZ0P) and received her second planned dose on 04 Mar 2021 (batch number: 029A21A) intramuscularly for prophylaxis of COVID-19 infection.   On 04 Mar 2021, the patient had bad headaches all night long.  On 05 Mar 2021, her blood sugar was 285 (unit not reported) in the morning when she woke up. Her right arm was sore. However, she did not have any fever, nausea or vomiting. Treatment information was not available at the time of this report.  Action taken with mRNA-1273 in the response to the events was not applicable.  The outcome of the events sore arm, bad headaches all night long and blood sugar was 285 was unknown. =; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Wound
Clinical narrative: 2nd dose at the end of March2020; severe cut on leg; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose at the end of March2020) and WOUND (severe cut on leg) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029420A) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy. Concurrent medical conditions included Cancer (Chronic cancer).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced WOUND (severe cut on leg). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose at the end of March2020). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose at the end of March2020) and WOUND (severe cut on leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received tetanus shot because she had severe cut. Due to that 2nd dose is scheduled on different date then usual scheduled date.  In the follow-up form patient states that she did receive 2nd dose nearly 2 months after the first one &  few days after she had chemotherapy.  Concomitant medication information was not provided.  Treatment information were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Received on 20 Jul 2021, patient updated about second dose
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure decreased, Eye pruritus, Heart rate increased, Oxygen saturation abnormal, Paraesthesia
Clinical narrative: itchy hands; itchy eyes; feels prickly; vision: car lit looks spikey with a lot of radiance; increase heart rate to 100bpm; BP reading of 90/52; O2 sat 92%; possible fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy hands), EYE PRURITUS (itchy eyes), PARAESTHESIA (feels prickly), VISUAL IMPAIRMENT (vision: car lit looks spikey with a lot of radiance) and HEART RATE INCREASED (increase heart rate to 100bpm) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included Xorelto                                                        blood thinner, Benicar                                                        for hypertension, Hydrochlorothiazide                                            diuretic, Naproxen                                                       for inflammation, Paroxetine                                                     for depression, Crestor                                                        for cholesterol, Vitamin D                                                      supplemental and Calmeg + Zinc                                                  supplemental for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PRURITUS (itchy hands), EYE PRURITUS (itchy eyes), PARAESTHESIA (feels prickly), VISUAL IMPAIRMENT (vision: car lit looks spikey with a lot of radiance), HEART RATE INCREASED (increase heart rate to 100bpm), BLOOD PRESSURE DECREASED (BP reading of 90/52), OXYGEN SATURATION ABNORMAL (O2 sat 92%) and PYREXIA (possible fever). On 07-Mar-2021, PRURITUS (itchy hands), EYE PRURITUS (itchy eyes), PARAESTHESIA (feels prickly), VISUAL IMPAIRMENT (vision: car lit looks spikey with a lot of radiance), HEART RATE INCREASED (increase heart rate to 100bpm), BLOOD PRESSURE DECREASED (BP reading of 90/52), OXYGEN SATURATION ABNORMAL (O2 sat 92%) and PYREXIA (possible fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Visual impairment
Clinical narrative: itchy hands; itchy eyes; feels prickly; vision: car lit looks spikey with a lot of radiance; increase heart rate to 100bpm; BP reading of 90/52; O2 sat 92%; possible fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy hands), EYE PRURITUS (itchy eyes), PARAESTHESIA (feels prickly), VISUAL IMPAIRMENT (vision: car lit looks spikey with a lot of radiance) and HEART RATE INCREASED (increase heart rate to 100bpm) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included Xorelto                                                        blood thinner, Benicar                                                        for hypertension, Hydrochlorothiazide                                            diuretic, Naproxen                                                       for inflammation, Paroxetine                                                     for depression, Crestor                                                        for cholesterol, Vitamin D                                                      supplemental and Calmeg + Zinc                                                  supplemental for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PRURITUS (itchy hands), EYE PRURITUS (itchy eyes), PARAESTHESIA (feels prickly), VISUAL IMPAIRMENT (vision: car lit looks spikey with a lot of radiance), HEART RATE INCREASED (increase heart rate to 100bpm), BLOOD PRESSURE DECREASED (BP reading of 90/52), OXYGEN SATURATION ABNORMAL (O2 sat 92%) and PYREXIA (possible fever). On 07-Mar-2021, PRURITUS (itchy hands), EYE PRURITUS (itchy eyes), PARAESTHESIA (feels prickly), VISUAL IMPAIRMENT (vision: car lit looks spikey with a lot of radiance), HEART RATE INCREASED (increase heart rate to 100bpm), BLOOD PRESSURE DECREASED (BP reading of 90/52), OXYGEN SATURATION ABNORMAL (O2 sat 92%) and PYREXIA (possible fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain, Vaccination site rash
Clinical narrative: Some fatigue off and on; Sensation in my left ear; Got  real dizzy, Could hardly get out of bed because I was so dizzy and could not focus my eyes, Severe dizziness; Took temperature 102.5 F; Big rash about size of apple below injection site; Feeling severely cold; I had a terrible bad day yesterday; Mild pain at injection site for two days; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Feeling severely cold), FEELING ABNORMAL (I had a terrible bad day yesterday), EAR DISCOMFORT (Sensation in my left ear), DIZZINESS (Got  real dizzy, Could hardly get out of bed because I was so dizzy and could not focus my eyes, Severe dizziness) and PYREXIA (Took temperature 102.5 F) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CLINDAMYCIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATENOLOL, MIDODRINE and TIOTROPIUM BROMIDE (SPIRIVA HANDIHALER) for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced FEELING COLD (Feeling severely cold), FEELING ABNORMAL (I had a terrible bad day yesterday), PYREXIA (Took temperature 102.5 F) and VACCINATION SITE RASH (Big rash about size of apple below injection site). On 18-Mar-2021, the patient experienced EAR DISCOMFORT (Sensation in my left ear) and DIZZINESS (Got  real dizzy, Could hardly get out of bed because I was so dizzy and could not focus my eyes, Severe dizziness). On an unknown date, the patient experienced VACCINATION SITE PAIN (Mild pain at injection site for two days) and FATIGUE (Some fatigue off and on). The patient was treated with MECLIZINE [MECLOZINE] on 22-Mar-2021 at a dose of 1 dosage form. On 07-Mar-2021, FEELING ABNORMAL (I had a terrible bad day yesterday) had resolved. At the time of the report, FEELING COLD (Feeling severely cold), EAR DISCOMFORT (Sensation in my left ear), DIZZINESS (Got  real dizzy, Could hardly get out of bed because I was so dizzy and could not focus my eyes, Severe dizziness), PYREXIA (Took temperature 102.5 F), VACCINATION SITE RASH (Big rash about size of apple below injection site), VACCINATION SITE PAIN (Mild pain at injection site for two days) and FATIGUE (Some fatigue off and on) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable   Most recent FOLLOW-UP information incorporated above includes: On 23-Mar-2021: Added events mild pain at injection site, fatigue, sensation in my left ear , got real dizzy, could hardly get out of bed because I was so dizzy and could not focus my eyes and severe dizziness, all having outcome unknown.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Urine odour abnormal
Clinical narrative: urine had a very strong odor like after eating a lot of asparagus; soreness in arm; felt a little tired; a little headache; This spontaneous case was reported by a consumer and describes the occurrence of URINE ODOUR ABNORMAL (urine had a very strong odor like after eating a lot of asparagus), MYALGIA (soreness in arm), FATIGUE (felt a little tired) and HEADACHE (a little headache) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included ATORVASTATIN, FAMOTIDINE, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HCTZ), VITAMIN D NOS, ALPHA LIPOIC ACID and FISH OIL for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URINE ODOUR ABNORMAL (urine had a very strong odor like after eating a lot of asparagus), MYALGIA (soreness in arm), FATIGUE (felt a little tired) and HEADACHE (a little headache). At the time of the report, URINE ODOUR ABNORMAL (urine had a very strong odor like after eating a lot of asparagus), MYALGIA (soreness in arm), FATIGUE (felt a little tired) and HEADACHE (a little headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Nausea
Clinical narrative: chills; body aches; constant nausea "worse than carbon monoxide poisoning"; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Mar-2021 and was forwarded to Moderna on 07-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), MYALGIA (body aches) and NAUSEA (constant nausea "worse than carbon monoxide poisoning") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), MYALGIA (body aches) and NAUSEA (constant nausea "worse than carbon monoxide poisoning"). At the time of the report, CHILLS (chills), MYALGIA (body aches) and NAUSEA (constant nausea "worse than carbon monoxide poisoning") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications are provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Second dose scheduled past 36 day mark post first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose scheduled past 36 day mark post first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose scheduled past 36 day mark post first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose scheduled past 36 day mark post first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-035610 (Patient Link).; Reporter's Comments: This report refers to a case of Inappropriate schedule of product administration for mRNA-1273, lot# unknown, with no associated adverse events.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Limb discomfort, Nausea, Pyrexia
Clinical narrative: felt tired; shaking; whole body shivering; felt her body was very heavy; had a 101.2-103.1 fever; nauseous; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Mar-2021 and was forwarded to Moderna on 07-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking), CHILLS (whole body shivering), LIMB DISCOMFORT (felt her body was very heavy), PYREXIA (had a 101.2-103.1 fever) and NAUSEA (nauseous) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013Az1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021 at 2:00 AM, the patient experienced TREMOR (shaking), CHILLS (whole body shivering), LIMB DISCOMFORT (felt her body was very heavy), PYREXIA (had a 101.2-103.1 fever) and NAUSEA (nauseous). On 04-Mar-2021 at 6:00 AM, the patient experienced FATIGUE (felt tired). On 04-Mar-2021, TREMOR (shaking), CHILLS (whole body shivering), LIMB DISCOMFORT (felt her body was very heavy) and PYREXIA (had a 101.2-103.1 fever) had resolved. On 04-Mar-2021 at 6:00 AM, NAUSEA (nauseous) had resolved. At the time of the report, FATIGUE (felt tired) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       She took Tylenol for the fever.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: felt tired; shaking; whole body shivering; felt her body was very heavy; had a 101.2-103.1 fever; nauseous; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Mar-2021 and was forwarded to Moderna on 07-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking), CHILLS (whole body shivering), LIMB DISCOMFORT (felt her body was very heavy), PYREXIA (had a 101.2-103.1 fever) and NAUSEA (nauseous) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013Az1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021 at 2:00 AM, the patient experienced TREMOR (shaking), CHILLS (whole body shivering), LIMB DISCOMFORT (felt her body was very heavy), PYREXIA (had a 101.2-103.1 fever) and NAUSEA (nauseous). On 04-Mar-2021 at 6:00 AM, the patient experienced FATIGUE (felt tired). On 04-Mar-2021, TREMOR (shaking), CHILLS (whole body shivering), LIMB DISCOMFORT (felt her body was very heavy) and PYREXIA (had a 101.2-103.1 fever) had resolved. On 04-Mar-2021 at 6:00 AM, NAUSEA (nauseous) had resolved. At the time of the report, FATIGUE (felt tired) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       She took Tylenol for the fever.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Feeling hot, Hot flush, Malaise
Clinical narrative: Felt a lot of heat in her body; Hot flashes; Had a dry mouth; Felt lousy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Felt a lot of heat in her body), HOT FLUSH (Hot flashes), DRY MOUTH (Had a dry mouth) and MALAISE (Felt lousy) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2020.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced FEELING HOT (Felt a lot of heat in her body), HOT FLUSH (Hot flashes), DRY MOUTH (Had a dry mouth) and MALAISE (Felt lousy). At the time of the report, FEELING HOT (Felt a lot of heat in her body), HOT FLUSH (Hot flashes), DRY MOUTH (Had a dry mouth) and MALAISE (Felt lousy) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications were not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Outcome of events provided
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema
Clinical narrative: Extreme arm itching 6 days after 1st dose; Red from injection to elbow 6 days after 1st dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Extreme arm itching 6 days after 1st dose) and VACCINATION SITE ERYTHEMA (Red from injection to elbow 6 days after 1st dose) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011m20a) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PRURITUS (Extreme arm itching 6 days after 1st dose) and VACCINATION SITE ERYTHEMA (Red from injection to elbow 6 days after 1st dose). At the time of the report, PRURITUS (Extreme arm itching 6 days after 1st dose) and VACCINATION SITE ERYTHEMA (Red from injection to elbow 6 days after 1st dose) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include hypertension meds and vitamins. Treatment included Alcohol and Gold Band   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow-up information received on 07 MAY 2021 contains No new information
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue
Clinical narrative: low level of fatigue; shoulder is sore in one certain spot; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (low level of fatigue) and ARTHRALGIA (shoulder is sore in one certain spot) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (low level of fatigue) and ARTHRALGIA (shoulder is sore in one certain spot). At the time of the report, FATIGUE (low level of fatigue) and ARTHRALGIA (shoulder is sore in one certain spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Dyspnoea, Illness, Myalgia, Nausea
Clinical narrative: Shortness of breath; cold sweats; Skin is crawling; not feeling good; sore arm; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), COLD SWEAT (cold sweats), PARAESTHESIA (Skin is crawling), ILLNESS (not feeling good) and MYALGIA (sore arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath), COLD SWEAT (cold sweats), PARAESTHESIA (Skin is crawling), ILLNESS (not feeling good), MYALGIA (sore arm) and NAUSEA (nausea). At the time of the report, DYSPNOEA (Shortness of breath), COLD SWEAT (cold sweats), PARAESTHESIA (Skin is crawling), ILLNESS (not feeling good) and NAUSEA (nausea) outcome was unknown and MYALGIA (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications includes Blood pressure, Thyroid medicine, Food appetizer. No treatment information were reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Shortness of breath; cold sweats; Skin is crawling; not feeling good; sore arm; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), COLD SWEAT (cold sweats), PARAESTHESIA (Skin is crawling), ILLNESS (not feeling good) and MYALGIA (sore arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath), COLD SWEAT (cold sweats), PARAESTHESIA (Skin is crawling), ILLNESS (not feeling good), MYALGIA (sore arm) and NAUSEA (nausea). At the time of the report, DYSPNOEA (Shortness of breath), COLD SWEAT (cold sweats), PARAESTHESIA (Skin is crawling), ILLNESS (not feeling good) and NAUSEA (nausea) outcome was unknown and MYALGIA (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications includes Blood pressure, Thyroid medicine, Food appetizer. No treatment information were reported.